Professor Robert Storey is Professor of Cardiology at the University of Sheffield, Sheffield, UK, where he has headed a thrombosis research group since 2002 and is director of the Cardiovascular Research Unit. He is also Academic Director and honorary Consultant Cardiologist for the Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals NHS Foundation Trust. He has a special interest in the management of ischaemic heart disease, including acute coronary syndromes and coronary intervention.
He was Chair of the ESC Working Group on Thrombosis 2012-14 and has served on several ESC guidelines task forces (chronic coronary syndromes 2019, NSTE ACS 2011 and 2015, dyslipidaemias 2011). He is/has been a member of numerous executive/steering committees for clinical trials in patients with ischaemic heart disease, such as PLATO, PEGASUS-TIMI 54, AUGUSTUS and COMPLETE.
2018 Joint European Consensus Document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease